Publication
New rules for MDEL holders: Health Canada’s terms and conditions authority
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
Global | Publication | August 2018
Most houses in multiple occupation (HMOs) in England comprising three storeys or more and occupied by five or more people in two or more separate households are subject to mandatory licensing by local housing authorities (LHAs).
A reminder that from October 1, 2018, the scope of mandatory HMO licensing will extend to apply to HMOs occupied by five persons or more in two or more households regardless of the number of storeys. Landlords of HMOs falling within the extended description who fail to apply for a licence by October 1, will commit a criminal offence.
LHAs will also be required to include the following conditions in all HMO licences granted or renewed on or after October 1, 2018:
Subject to a limited transitional period for the first two conditions, licence holders not complying with a condition will commit a criminal offence and be liable to an unlimited fine, or a financial penalty of up to £30,000.
It is estimated that the extension of the scope of mandatory licensing will result in an additional 160,000 HMOs needing to be licensed. HMO landlords and managers would do well to consider now whether they need to take action before the October deadline.
Publication
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
Publication
Early January is a good time to take stock of workplace law developments that arose in 2024, and how those developments may evolve in 2025.
Publication
As you prepare for your next AGM, stay up-to-date on key developments in Canadian corporate and securities legislation, corporate governance guidance and institutional shareholder proxy voting guidelines that may impact the management information circular for your 2025 annual shareholder meeting and your 2025 annual disclosure filings.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025